"At Providence, we know how terrifying a cancer diagnosis is. We are here to provide the best possible cancer care, counseling and support for you. Our Cancer Center in Centralia provides you with the regular treatments you need, close to home. You can have appointments with your specialists and get your treatments without the expense, discomfort and stress of traveling out of town. We will help you and your family navigate through your cancer journey with the best medical treatment and support we can offer. We also want to make it convenient, which is why our extensive network of care gives you access to expanded chemotherapy and radiation therapy services right here in Lewis County."

During the past decade, Providence Regional Cancer System-Centralia conducted 142 clinical trials. In the 10-year time frame, 142 clinical trials started and 78 clinical trials were completed, i.e. on average, 54.9% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 57 clinical trials were completed. i.e. 98.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Regional Cancer System-Centralia" #1 sponsor was "National Cancer Institute (NCI)" with 104 trials, followed by "SWOG Cancer Research Network" with 37 trials sponsored, "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "Gynecologic Oncology Group" with 16 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Regional Cancer System-Centralia" #1 collaborator was "National Cancer Institute (NCI)" with 105 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 6 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Providence Regional Cancer System-Centralia" are "Invasive Breast Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (8 trials) and "Cervical Adenocarcinoma" (7 trials). Many other conditions were trialed in "Providence Regional Cancer System-Centralia" in a lesser frequency.

Most popular intervention types in "Providence Regional Cancer System-Centralia" are "Drug" (172 trials), "Other" (127 trials), "Biological" (99 trials), "Procedure" (57 trials) and "Radiation" (30 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (68 trials), "Quality-of-Life Assessment" (56 trials), "Questionnaire Administration" (33 trials), "Computed Tomography" (30 trials) and "Paclitaxel" (30 trials). Other intervention names were less common.

The vast majority of trials in "Providence Regional Cancer System-Centralia" are 169 trials for "All" genders, 38 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Regional Cancer System-Centralia". undefined are not yet recruiting, 56 are recruiting, 100 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Providence Regional Cancer System-Centralia, 5 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Regional Cancer System-Centralia, 5 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 114 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".